RGMB antibody (C-Term)
Quick Overview for RGMB antibody (C-Term) (ABIN5532028)
Target
See all RGMB AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 376-406, C-Term
-
Purification
- This antibody is purified through a protein G column, followed by dialysis against PBS.
-
Immunogen
- This DRAGON (RGMB) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 376-406 amino acids from the C-terminal region of human DRAGON (RGMB).
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
-
For WB starting dilution is: 1:2000
For IHC-P starting dilution is: 1:10~50 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- RGMB (RGM Domain Family, Member B (RGMB))
-
Alternative Name
- DRAGON
-
Background
- Repulsive Guidance Molecule B (RGMB) is primarily expressed in the central nervous system. RGM A and B both appear at every level of the developing neural axis, where they colocalize to a large extent in the mantle layer, although only RGMA appears in the neuroepithelium, and only RGMB in the peripheral nervous system. During development, both RGMA and B appear also in lung and in limb cartilage, while RGMB has additional expression domains in pancreas.
-
Molecular Weight
- 48 kDa
-
Gene ID
- 285704
-
UniProt
- Q6NW40
Target
-